GenusPlus Group Ltd (ASX:GNP) Secures $130 Million NBN Contract
GenusPlus Group Ltd (ASX:GNP) secures a $130 million contract with NBN Co to upgrade fiber infrastructure across Western Australia.
GenusPlus Group Ltd (ASX:GNP) secures a $130 million contract with NBN Co to upgrade fiber infrastructure across Western Australia.
PYC Therapeutics (ASX:PYC) receives approval to escalate dosing in its ADOA clinical trial, advancing development of its PYC-001 drug candidate.
4DMedical Limited (ASX:4DX) partners with Olympus to deploy AI-powered SeleCT™ Screening, enhancing COPD diagnosis and treatment.
Siren Gold Limited (ASX:SNG) reports significant gold and antimony grades from its Langdons project, highlighting exploration progress and next steps.
Radiopharm Theranostics (ASX:RAD) secures FDA Fast Track for RAD101, advancing its Phase 2 trial in brain metastases imaging.
Fletcher Building (ASX:FBU) receives inquiries following strategic review, with further details to be disclosed at Investor Day.
Finbar Group Limited (ASX:FRI) appoints Ronald Chan as CEO ahead of schedule, emphasizing leadership stability and future growth.
Zip Co Limited (ASX:ZIP) upgrades FY25 guidance to $160m cash EBTDA, citing strong May performance and US TTV growth above 40%.
Zenith Minerals (ASX:ZNC) acquires exclusive subsurface rights to expand its Dulcie Gold Project, enhancing exploration and reducing operational risks.
Centrex Limited (ASX:CXM) reconvenes its second creditors meeting, proposing a DOCA by PRL Global Limited.